mAb therapeutic products and risk management.
Reichert
Janice M
JM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001709:Biotechnology; D017723:Drug Utilization Review; D007167:Immunotherapy; D017410:Practice Guidelines as Topic; D055656:Prescriptions; D018570:Risk Assessment; D012308:Risk Management / Q000331:legislation & jurisprudence / Q000458:organization & administration; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal